Volume : 12, Issue : 01, January – 2025
Title:
INTEGRATED CANCER CARE: DIAGNOSIS, THERAPIES AND FUTURE TRENDS
Authors :
Gangasagar U. Shinde, Aditya A. Unhale, Swati P. Deshmukh
Abstract :
Cancer remains one of the world’s most critical health challenges, with millions of cases diagnosed each year globally. It is a complex disease characterized by uncontrolled cell growth, which can invade other tissues and spread through the blood and lymphatic systems. There are over 100 types of cancer, with the most common being lung, breast, colon, and prostate cancers. Cancers are broadly categorized into carcinomas, sarcomas, lymphomas, leukemias, and myelomas. Carcinomas affect epithelial tissues, while sarcomas develop from connective tissues such as bones and muscles. Lymphomas impact the lymphatic system, leukemias target blood and bone marrow, and myelomas originate from plasma cells in the bone marrow.
Diagnosis plays a crucial role in managing cancer, with imaging techniques such as X-rays, CT scans, MRIs, and PET scans being widely used. A precise diagnosis is essential to determine the type and extent of cancer, aiding personalized treatment strategies.Cancer therapies include a combination of surgery, radiation therapy, and chemotherapy. Recent advancements have introduced targeted therapies aimed at specific molecular pathways and immunotherapy, which harnesses the immune system to fight cancer cells. Additionally, therapies like hormone therapy, stem cell transplants, and nanotechnology-based treatments are emerging to improve patient outcomes. Despite significant progress, challenges persist, such as cancer recurrence due to residual cancer stem cells. Research efforts are increasingly focused on eradicating these cells to prevent metastasis and relapses. Multiple risk factors contribute to cancer development, including genetic predisposition, environmental exposure, smoking, poor diet, and lack of physical activity. Efforts to mitigate risks through lifestyle changes, early detection, and public health awareness are crucial for reducing cancer incidence and mortality.
Keyword: Cancer, Diagnosis, Imaging techniques, X-rays, CT scans, MRIs, PET scans, Treatment strategies
Cite This Article:
Please cite this article in press Gangasagar U. Shinde et al., Integrated Cancer Care: Diagnosis, Therapies And Future Trends.,Indo Am. J. P. Sci, 2025; 12 (01).
Number of Downloads : 10
References:
1. Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010). The global burden of cancer: Priorities for prevention. Carcinogenesis, 31(1), 100–110.
2. Sifri R, Gangadharappa S, Acheson LS. Identifying and testing for hereditary susceptibility to common cancers. CA Cancer J Clin. 2004; 54(6): 309–26.
3. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. OnkologiapoDyplomie. 2004; 1(5): 25–48.
4. Schulz M, Hoffmann K, Weikert C, Nöthlings U, Schulze MB, Boeing H. Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 2008; 100(5): 942–946
5. Burger M, et al. Epidemiology and Risk Factors of Urothelial Bladder Cancer. European Urology. 2013; 63(2): 234–241.
6. Batycka-Baran A, Kuczborska I, Szepietowski J. Vitamin D and Malignant melanoma – review of the literature. ClinDermatol. 2012; 14(1): 37–41.
7. Leon ME, Peruga A, McNeill A, Kralikova E, Guha N, Minozzi S, Espina C, Schüz J. European Code against Cancer, 4th Edition: Tobacco and Cancer. Cancer Epidemiol. 2015; 39(1): 20–33.10.1016/j.Canep.2015.06.001.
8. Chybicka A. Influence of mother’s diet during pregnancy on cancer incidence in children. Prevention activities. Pol Med Rodz. 2004; 6(3): 1213–1215.
9. Lajous M, Lazcano-Ponce E, Hernandez-Avila M, Willett W, Romieu I. Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast Cancer among Mexican women. Cancer Epidemiol Biomarkers Prev.2006; 15(3): 443–8.
10. Przybylska D, Kurowska M, Przybylski P. Obesity and overweight in The adolescent population. Hygeia Public Health. 2012; 47(1): 28–35.
11. Peterson E, Prithwish D, Nuttall R. BMI, diet and female reproductive Factors as risks for thyroid cancer: a systematic review. PLoS One. 2012; 7(1).
12. Peterson E, Prithwish D, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One. 2012; 7(1).
13. Szkaradkiewicz A. Microbes and oncogenesis. Contemporary Oncol. 2003; 7(2): 96–101.
14. Chybicka A. Influence of mother’s diet during pregnancy on cancer Incidence in children. Prevention activities. Pol Med Rodz. 2004; 6(3): 1213–1215.
15. González CA, Agudo A. Carcinogenesis, prevention and early detection Of oastric cancer: where we are and where we should go. Int J Cancer.2012; 130: 745–753,
16. Litjens, G., et al. (2017). “A Survey on Deep Learning in Medical Image Analysis.” Medical Image Analysis.
17. Suzuki, K. (2017). “Overview of Deep Learning in Medical Imaging.” Radiology
18. Blum RH, Carter SK. Adriamycin. A new anticancer drug with significantClinical activity. Ann Intern Med 80(2):249-59 (1974) .
19. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and Daunorubicin. BiochemPharmacol 57(7):727-741 (1999).
20. Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL. Cleavage of DNA bymammalian DNA topoisomerase II. J BiolChem 258(24):15365-15370 (1983).